Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress

Cytotherapy

Volumn 14, Issue 1, 2012, Pages 45-55

  Yust Katz, Shlomit ^a   Fisher Shoval, Yonit ^b   Barhum, Yael ^b   Ben Zur, Tali ^b   Barzilay, Ran ^b   Lev, Nirit ^a,b   Hod, Moshe ^a   Melamed, Eldad ^a,b   Offen, Daniel ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

mesenchymal stromal cells; neuroprotection; placenta

Indexed keywords

BEVACIZUMAB; NEUROTROPHIC FACTOR; VASCULOTROPIN;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOLOGY; MESENCHYMAL STROMA CELL; MESENCHYME CELL; NEUROPROTECTION; OSTEOBLAST; OXIDATIVE STRESS; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STROMA CELL;

EID: 83755188615     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.613928     Document Type: Article

References (32)

1. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;4:27671-4.
2. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19:180-92. (Pubitemid 32524539)
3. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. Embryol Exp Morphol. 1966;16:381-90.
4. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, et al. Precursors for fi broblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2: 83-92.
5. Friedenstein AJ, Gorskaja U, Kalugina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-74.
6. Eriksson PS, Perfi lieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nature Med. 1998;4: 1313-17. (Pubitemid 28512114)
7. Li WL, Yu SP, Ogle ME, Ding XS, Wei L. Enhanced neurogenesis and cell migration following focal ischemia and peripheral stimulation in mice. Dev Neurobiol. 2008;68:1474-86.
8. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature Rev Immunol. 2008;8:726-36.
9. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells. 2004;22:649-58. (Pubitemid 39166923)
10. Cetrulo CL, Cetrulo KJ. Placental and pregnancy stem cells: Everyone is, or should be, interested in the placenta. Stem Cell Rev. 2006;2:79-80. (Pubitemid 46132373)
11. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, et al. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008;17:1095-107.
12. Li C, Zhang W, Jiang X, Mao N. Human placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell Tissue Res. 2007;330: 437-46. (Pubitemid 350098216)
13. Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Exp Hematol. 2008;36: 1370-6.
14. Fazekasova H, Lechler R, Langford K, Lombardi G. Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs. J Tissue Eng Regen Med. 2011;5:684-94.
15. Barhum Y, Gai-Castro S, Bahat-Stromza M, Barzilay R, Melamed E, Offen D. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci. 2010;41:129-37.
16. Bahat-Stroomza M, Barhum Y, Levy YS, Karpov O, Bulvik S, Melamed E, et al. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: Potential for restorative treatment in Parkinson s disease. J Mol Neurosci 2009;39:199-210.
17. Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, et al. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson s disease. Cytotherapy. 2008;10:340-52. (Pubitemid 351983158)
18. Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, et al. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev. 2009;18:1179-90.
19. Schallmoser K, Strunk D. Preparation of pooled human platelet lysate (pHPL) as an effi cient supplement for animal serum-free human stem cell cultures. Journal of Visualized Experiments JoVE. 2009;32:20-23.
20. Brewer GJ, Torricelli JR. Isolation and culture of adult neurons and neurospheres. Nat Protoc. 2007;2:1490-8. (Pubitemid 46952327)
21. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I,Marini F, Krause D, et al. Minimal criteria for defiing multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-17. (Pubitemid 44269669)
22. Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gomez-Diaz R, Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci. 2008;11:755-61. (Pubitemid 351896676)
23. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores- Guzm ánP, Hern á ndez-Estévez E, Fajardo-Orduña G, et al. Human mesenchymal stromal cells from adult and neonatal sources: Comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy. 2009;11:163-76.
24. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78:1439-48. (Pubitemid 39552929)
25. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;8;246:1306-9. (Pubitemid 20066716)
26. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-12. (Pubitemid 20066717)
27. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci. 1999; 19:5731-40. (Pubitemid 29327910)
28. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the fl k-1 receptor. Eur J Neurosci. 2000;12: 4243-54. (Pubitemid 32037835)
29. Silverman WF, Krum JM, Mani N, Rosenstein JM. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience. 1999;90: 1529-41. (Pubitemid 29170166)
30. Rosen SW. New placental proteins: Chemistry, physiology and clinical use. Placenta. 1986;7:575-94. (Pubitemid 17187500)
31. Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3(4):e1886.
32. Kranz A, Wagner DC, Kamprad M, Scholz M, Schmidt UR, Nitzsche F, et al. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res. 2010;1315:128-36.